MyndTec Inc. specializes in developing therapies for individuals with paralysis from stroke or spinal cord injuries. The company faces significant financial challenges, highlighted by a gross margin of -17.0% and an EBITDA margin of -2032.6%, indicating severe operational inefficiencies. Additionally, a current ratio of 0.11 suggests liquidity concerns, raising questions about its ability to meet short-term obligations. The sharp 50% drop in stock price today further underscores market apprehension regarding its financial stability and growth prospects.
Loading financial metrics...
Company has $90K in cash but burned $240K last quarter. At this burn rate, only 0.4 quarters of runway remain without additional financing.
Company posted a loss of $-1.1M over the last year, representing 824.3% of revenue.
Debt of $430K is 4.8x the company's cash position of $90K.
Operating cash flow has been negative for 3 consecutive quarters, burning $961K over the last year.
Revenue growing at 10.9% YoY, outpacing typical market growth rates.
Gross margin expanded by 38.0 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 230.7pp, demonstrating strong operational leverage.
Both gross margin (+38.0pp) and operating margin (+230.7pp) are expanding simultaneously, indicating the company is scaling profitably.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical - Devices companies of a similar size
Based on 2025-Q3 (September 30, 2025)